Cytochalasin-stimulated steroidogenesis from high density lipoproteins.
The cytochalasins stimulate steroid secretion of Y-1 adrenal tumor cells two-to threefold. The order of potencies is cytochalasin E is greater than D is greater than B, but the maximum response is the the same and always less than with ACTH. Like that with ACTH, the stimulation has a rapid onset, is easily reversible, is inhibited by cucloheximide and aminoglutethimide, and occurs at a stage before pregnenolone. Although the cytochalasin, like ACTH, produce cell rounding, it is shown that this morphological change is not necessarily coupled to steridogenesis. Unlike ACTH, cytochalasin B does not measurably increase cellular levels of cAMP at concentrations that lead to maximal steroidogenesis. The cytochalasin B-induced stimulation of steroidogenesis, unlike the short-term ACTH effect, fails to occur in the absence of serum. This lack of response can be corrected by even low concentrations of human high density lipoproteins (HDL) but not by low density lipoproteins (LDL). We, therefore, propose that cytochalasin B enhances the availability of cholesterol bound to HDL for steroidogenesis by Y-1 adrenal cells.
D004092:20-alpha-Dihydroprogesterone / Q000096:biosynthesis*; D000310:Adrenal Gland Neoplasms; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000616:Aminoglutethimide / Q000494:pharmacology; D002460:Cell Line; D003513:Cycloheximide / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D003572:Cytochalasins / Q000494:pharmacology*; D004336:Drug Antagonism; D008075:Lipoproteins, HDL / Q000378:metabolism*; D011374:Progesterone / Q000031:analogs & derivatives*; D013268:Stimulation, Chemical
D003572:Cytochalasins; D008075:Lipoproteins, HDL; D000616:Aminoglutethimide; D004092:20-alpha-Dihydroprogesterone; D003571:Cytochalasin B; D011374:Progesterone; D000324:Adrenocorticotropic Hormone; D003513:Cycloheximide